123 related articles for article (PubMed ID: 25490700)
1. Hydroxamic acids block replication of hepatitis C virus.
Ai T; Xu Y; Qiu L; Geraghty RJ; Chen L
J Med Chem; 2015 Jan; 58(2):785-800. PubMed ID: 25490700
[TBL] [Abstract][Full Text] [Related]
2. Pyridine hydroxamic acids are specific anti-HCV agents affecting HDAC6.
Kozlov MV; Kleymenova AA; Romanova LI; Konduktorov KA; Kamarova KA; Smirnova OA; Prassolov VS; Kochetkov SN
Bioorg Med Chem Lett; 2015 Jun; 25(11):2382-5. PubMed ID: 25937017
[TBL] [Abstract][Full Text] [Related]
3. Structural isomers of cinnamic hydroxamic acids block HCV replication via different mechanisms.
Kozlov MV; Konduktorov KA; Malikova AZ; Kamarova KA; Shcherbakova AS; Solyev PN; Kochetkov SN
Eur J Med Chem; 2019 Dec; 183():111723. PubMed ID: 31557613
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.
Ai T; Qiu L; Xie J; Geraghty RJ; Chen L
Bioorg Med Chem; 2016 Feb; 24(4):686-92. PubMed ID: 26753813
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication.
Sato A; Saito Y; Sugiyama K; Sakasegawa N; Muramatsu T; Fukuda S; Yoneya M; Kimura M; Ebinuma H; Hibi T; Ikeda M; Kato N; Saito H
J Cell Biochem; 2013 Sep; 114(9):1987-96. PubMed ID: 23519646
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of N'-propylhydrazide analogs of hydroxamic inhibitors of histone deacetylases (HDACs) and evaluation of their impact on activities of HDACs and replication of hepatitis C virus (HCV).
Kozlov MV; Konduktorov KA; Shcherbakova AS; Kochetkov SN
Bioorg Med Chem Lett; 2019 Aug; 29(16):2369-2374. PubMed ID: 31201063
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes.
Kozlov MV; Kleymenova AA; Konduktorov KA; Malikova AZ; Kochetkov SN
Biochemistry (Mosc); 2014 Jul; 79(7):637-42. PubMed ID: 25108326
[TBL] [Abstract][Full Text] [Related]
8. Repurposing of HDAC inhibitors toward anti-hepatitis C virus drug discovery: teaching an old dog new tricks.
Zhao F; Liu N; Zhan P; Liu X
Future Med Chem; 2015; 7(11):1367-71. PubMed ID: 26230876
[No Abstract] [Full Text] [Related]
9. 5-membered cyclic hydroxamic acids as HDAC inhibitors.
Mutule I; Borovika D; Rozenberga E; Romanchikova N; Zalubovskis R; Shestakova I; Trapencieris P
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):216-23. PubMed ID: 24939099
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
Pabba C; Gregg BT; Kitchen DB; Chen ZJ; Judkins A
Bioorg Med Chem Lett; 2011 Jan; 21(1):324-8. PubMed ID: 21109435
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW
J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149
[TBL] [Abstract][Full Text] [Related]
12. Benzohydroxamic acids as potent and selective anti-HCV agents.
Kozlov MV; Kleymenova AA; Romanova LI; Konduktorov KA; Smirnova OA; Prasolov VS; Kochetkov SN
Bioorg Med Chem Lett; 2013 Nov; 23(21):5936-40. PubMed ID: 24035094
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.
Tashima T; Murata H; Kodama H
Bioorg Med Chem; 2014 Jul; 22(14):3720-31. PubMed ID: 24864038
[TBL] [Abstract][Full Text] [Related]
14. Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.
Rossi C; Porcelloni M; D'Andrea P; Fincham CI; Ettorre A; Mauro S; Squarcia A; Bigioni M; Parlani M; Nardelli F; Binaschi M; Maggi CA; Fattori D
Bioorg Med Chem Lett; 2011 Apr; 21(8):2305-8. PubMed ID: 21420859
[TBL] [Abstract][Full Text] [Related]
15. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
[TBL] [Abstract][Full Text] [Related]
17. Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors.
Angibaud P; Van Emelen K; Decrane L; van Brandt S; Ten Holte P; Pilatte I; Roux B; Poncelet V; Speybrouck D; Queguiner L; Gaurrand S; Mariën A; Floren W; Janssen L; Verdonck M; van Dun J; van Gompel J; Gilissen R; Mackie C; Du Jardin M; Peeters J; Noppe M; Van Hijfte L; Freyne E; Page M; Janicot M; Arts J
Bioorg Med Chem Lett; 2010 Jan; 20(1):294-8. PubMed ID: 19906529
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.
Clark JL; Mason JC; Hollecker L; Stuyver LJ; Tharnish PM; McBrayer TR; Otto MJ; Furman PA; Schinazi RF; Watanabe KA
Bioorg Med Chem Lett; 2006 Mar; 16(6):1712-5. PubMed ID: 16368235
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of novel diaryl ether hydroxamic acids derivatives as potential HDAC inhibitors.
Zhu Y; Chen X; Wu Z; Zheng Y; Chen Y; Tang W; Lu T
Arch Pharm Res; 2012 Oct; 35(10):1723-32. PubMed ID: 23139122
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.
Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM
J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
